Diabetes and Fatty Liver Disease: The Silent Connection Explained
How extra glucose is converted into stored fat inside your liver, why early fatty liver causes zero pain, and practical lifestyle habits to clear liver fat naturally.

During a routine abdominal ultrasound or blood test in Pakistan, many people with diabetes receive an unexpected result: 'Grade 1 or Grade 2 Fatty Liver' (metabolic dysfunction-associated steatotic liver disease, formerly NAFLD).
It is a common diagnosis—up to 70% of adults with Type 2 diabetes have excess fat accumulated inside their liver cells. Understanding how fatty liver develops helps you take proactive steps to reverse it.
Why the Name Changed From NAFLD to MASLD
For years this condition was called Non-Alcoholic Fatty Liver Disease (NAFLD) — a name defined by what it was not (alcohol-related) rather than what it actually was. In 2023, a joint effort by liver specialty societies renamed it metabolic dysfunction-associated steatotic liver disease (MASLD), a change the American Diabetes Association's consensus report (opens in a new tab) has since adopted. The new name does two useful things: it removes the stigmatising implication that the disease is caused by hidden drinking, and it ties the diagnosis directly to the metabolic drivers — insulin resistance, excess weight, high blood pressure, and abnormal blood fats — that actually cause it in the overwhelming majority of cases, including nearly everyone reading this with Type 2 diabetes.
The ADA, the American Association for the Study of Liver Diseases (AASLD), and the European Association for the Study of the Liver (opens in a new tab) now jointly recommend that all adults with Type 2 diabetes be screened for MASLD, because the disease itself produces no symptoms until it is advanced, and diabetes is one of its strongest risk multipliers.
How Insulin Resistance Drives Fatty Liver
Your liver is your body's master chemical factory. One of its main jobs is managing glucose and fat storage:
- 1Excess Carbs & Sugar Arrive: When you eat refined carbohydrates (maida, white rice, sweet drinks), glucose floods into the liver.
- 2Insulin Signals Fat Storage: High circulating insulin levels signal the liver to convert excess glucose into fat molecules (triglycerides) via a process called de novo lipogenesis.
- 3Fat Stays Trapped in Liver Cells: Instead of exporting fat, the liver begins storing fat drops inside its own tissues. Over time, fat makes up more than 5% to 10% of total liver weight.
Why Early Fatty Liver Has Zero Physical Pain
Like early diabetic kidney strain, early fatty liver causes no pain or discomfort. You cannot 'feel' fat accumulating in your liver. Most people discover it during routine ultrasound scans or when a liver function blood test (LFT) shows mildly elevated enzymes (ALT or AST).
The great news is that the liver has an extraordinary ability to regenerate and heal. Losing just 5% to 10% of total body weight dramatically reduces liver fat and lowers liver inflammation.
From Simple Fat to Scarring: Why Staging Matters
'Fatty liver' is not one fixed condition — it is a spectrum, and where you sit on it changes how seriously it needs to be taken. The disease typically progresses through stages: simple fat accumulation (steatosis) with no inflammation, then MASH (metabolic dysfunction-associated steatohepatitis, the more aggressive form with active liver inflammation), then fibrosis as scar tissue starts to replace healthy liver cells, and in a minority of people, eventually cirrhosis. Roughly half of people with MASLD progress to the inflamed MASH stage, and it is that stage which carries the real risk of long-term liver damage.
Because fat on an ultrasound alone doesn't reveal how much scarring, if any, has occurred, doctors increasingly use a simple blood-based calculation called the FIB-4 index — built from your age, ALT, AST and platelet count — to estimate fibrosis risk without a liver biopsy. If your FIB-4 or your doctor's exam suggests a higher risk, elastography (a specialised ultrasound that measures liver stiffness) is the usual next step. Ask your doctor whether a FIB-4 calculation is worth adding to your regular diabetes blood work; it costs nothing extra since it is calculated from tests you are likely already having.
3 Steps to Clear Liver Fat Naturally
- Cut Out Liquid Fructose & Sugary Sherbets: Packaged juices, sodas, and sweet tea deliver rapid fructose directly to the liver, fueling fat production. Choose plain water or green tea instead.
- Engage in Brisk Daily Walking: 30 minutes of daily walking contracts large leg muscles, pulling glucose and fats out of bloodstream storage before they reach the liver.
- Embrace Whole Wheat & Pulses: Swapping refined white flour for whole wheat chakki atta and fiber-rich lentils (daal) slows down nutrient delivery to the liver.
Where Diabetes Medicines Fit In
Lifestyle change remains the foundation of treatment, but it is not the only tool. Several diabetes medications have real, measured effects on liver fat as a side benefit of how they work. GLP-1 receptor agonists and SGLT2 inhibitors both reduce liver fat alongside their glucose and weight effects, and pioglitazone has the longest track record specifically for improving liver histology in people with MASH. None of these should be started for the liver alone without your doctor weighing your full picture — but if you are already being considered for one of them to manage your sugar, a coexisting fatty liver diagnosis is a reasonable point in favour of that choice, worth raising directly in the conversation with your doctor.
“Your liver is remarkably resilient—losing a small amount of weight clears liver fat and restores insulin sensitivity.”
Use Diatic to monitor your weight and daily walk logs alongside your blood glucose trends.
Frequently asked questions
Can drinking alcohol cause fatty liver in diabetes?
Yes. Alcohol accelerates liver fat accumulation. However, Metabolic Fatty Liver (MASLD) occurs in people who drink little to no alcohol, driven entirely by metabolic insulin resistance.
Are there specific medicines that treat fatty liver?
Certain diabetes medications (such as SGLT2 inhibitors and GLP-1 receptor agonists, or Pioglitazone) show great clinical benefits in reducing liver fat under physician guidance.
Why was Fatty Liver renamed MASLD?
The condition was renamed metabolic dysfunction-associated steatotic liver disease (MASLD) in 2023 by an international consensus of liver societies, adopted by the ADA, to reflect its true metabolic cause rather than defining it by the absence of alcohol use. The new name removes an unhelpful stigma and correctly points to insulin resistance, weight, blood pressure and cholesterol as the actual drivers in people with diabetes.
Does having a normal liver function test (LFT) mean my liver is fine?
Not necessarily. Liver enzymes like ALT and AST can stay in the normal range even with significant fat accumulation, especially early on. An ultrasound, a FIB-4 calculation, or specialised elastography give a more complete picture than enzyme levels alone — worth asking your doctor about if you have diabetes and have never had your liver specifically imaged.
Sources
- American Diabetes Association (ADA) (opens in a new tab)
- Baqai Institute of Diabetology and Endocrinology (BIDE) Pakistan (opens in a new tab)
- Pakistan Cardiac Society (PCS) / Pakistan Hypertension League (PHL) (opens in a new tab)
- American Diabetes Association (ADA) (opens in a new tab)
- American Academy of Dermatology (AAD) (opens in a new tab)
- DermNet NZ (opens in a new tab)
- Journal of Pakistan Association of Dermatologists — cutaneous manifestations of diabetes mellitus (PAF Hospital Sargodha and CMH Peshawar) (opens in a new tab)
- Kumar A, Basu R — Management of Cirrhosis in Diabetes: A Pragmatic Approach to the Patient, The Journal of Clinical Endocrinology & Metabolism (2026) (opens in a new tab)
- Hepatogenous Diabetes: A Primer — review, National Library of Medicine (PMC) (opens in a new tab)
- Advances in the treatment of hepatogenous diabetes — review, World Journal of Gastroenterology (PMC) (opens in a new tab)
- EASL Clinical Practice Guidelines on nutrition in chronic liver disease, Journal of Hepatology (PMC) (opens in a new tab)
- Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis — Digestive Diseases and Sciences (opens in a new tab)
- Journal of Hematology — Prevalence of Anemia in Type 2 Diabetic Patients (Amiri Hospital, Kuwait) (opens in a new tab)
- Diabetes Care — Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study (2020) (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Anemia in Chronic Kidney Disease (opens in a new tab)
- World Health Organization — Anaemia fact sheet (opens in a new tab)
- NHS — Iron deficiency anaemia (opens in a new tab)
- British Journal of Nutrition — Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages (opens in a new tab)
- American Journal of Clinical Nutrition — A 1-h time interval between a meal containing iron and consumption of tea attenuates the inhibitory effects on iron absorption (opens in a new tab)
- Nutrients / National Nutrition Survey 2018 — Prevalence and Risk Factors for Iron Deficiency Anemia among Children under Five and Women of Reproductive Age in Pakistan (opens in a new tab)
- World Health Organization — Obesity and overweight fact sheet (opens in a new tab)
- The Lancet — Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial (opens in a new tab)
- American Diabetes Association (ADA) — Obesity and Weight Management for the Prevention and Treatment of Diabetes, Standards of Care in Diabetes-2026 (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (opens in a new tab)
- NIDDK — Diabetes Discoveries & Practice (interview with Dr. Adil Bharucha) (opens in a new tab)
- Cureus — Frequency of Gastroparesis Symptoms in Patients With Type 2 Diabetes at a Tertiary Care Hospital in Pakistan (opens in a new tab)
- BMC Endocrine Disorders — systematic review and meta-analysis of gastrointestinal adverse events with metformin (opens in a new tab)
- National Health Service (NHS UK) (opens in a new tab)
Related reading

Diabetes and High Blood Pressure: Managing the Twin Strain
Why diabetes and hypertension frequently co-exist, how they multiply cardiovascular strain, and practical ways to keep both numbers in target range.

Diabetes and Obesity: Breaking the 'Diabesity' Cycle
Why visceral belly fat drives insulin resistance, understanding South Asian BMI standards, and how a modest 5% weight loss dramatically improves glucose numbers.

Diabetes and Thyroid Problems: How Hormones Intersect
Why thyroid dysfunction commonly co-occurs with diabetes, how an underactive thyroid slows metabolism, and managing both conditions smoothly.

Diabetes and Vitamin Deficiencies: The Role of Vitamin D & B12
Why people living with diabetes in Pakistan frequently experience low Vitamin D and B12 levels, and how proper testing and supplementation restore energy.